Muna Therapeutics

Copenhagen, Capital Region, Denmark

Company profile

Muna Therapeutics company profile

Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Parkinson's, Alzheimer's, Frontotemporal Dementia, and Multiple Sclerosis.

Business identity

Website: https://munatherapeutics.com/
Contact email: [email protected]
Operating status: Active
Company type: For Profit
Employee range: 11-50 employees
Revenue range: $0-$1M
Founded: 2020-01-01, Year

Headquarters

Headquarters: Copenhagen, Capital Region, Denmark
Country code: DK
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 3
Total equity funding: $73M
Last funding: Grant / $1M / 2026-01-08
Last equity funding: Series A / $73M
Investors: 10
Lead investors: 6
Founders: 2
Articles: 27

Categories and groups

Biopharma Biotechnology Medical Pharmaceutical Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Bart De StrooperSimon Glerup

Lead investors

Alzheimer's AssociationDroia VenturesLSP BioVenturesMichael J. Fox FoundationNovo HoldingsSofinnova Partners

Investors

Alzheimer's AssociationMichael J. Fox FoundationNovo HoldingsPolaris PartnersSofinnova Partners

Muna Therapeutics